Lipid vesicles for skin delivery of drugs: Reviewing three decades of research

被引：410

作者：

Elsayed, Mustafa M. A. ^{[1
]}

Abdallah, Ossama Y. ^{[1
]}

Naggar, Viviane F. ^{[1
]}

Khalafallah, Nawal M. ^{[1
]}

机构：

[1] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria 21521, Egypt

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2007年 / 332卷 / 1-2期

关键词：

lipid vesicles; liposomes; deformable liposomes; ethosomes; skin delivery; topical; transdermal; mechanism of action;

D O I：

10.1016/j.ijpharm.2006.12.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Since liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, studies continued towards further investigation and development of lipid vesicles as carriers for skin delivery of drugs. Despite this long history of intensive research, lipid vesicles are still considered as a controversial class of dermal and transdermal carriers. Accordingly, this article provides an overview of the development of lipid vesicles for skin delivery of drugs, with special emphasis on recent advances in this field, including the development of deformable liposomes and ethosomes. (c) 2006 Elsevier B.V. All rights reserved.

引用

页码：1 / 16

页数：16

共 128 条

[1] INTERACTION BETWEEN CORNEOCYTES AND STRATUM-CORNEUM LIPID LIPOSOMES INVITRO [J].

ABRAHAM, W ;

DOWNING, DT .

BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1021 (02) :119-125

[2] The pilosebaceous unit: A pivotal route for topical drug delivery [J].

Agarwal, R ;

Katare, OP ;

Vyas, SP .

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (02) :129-133

[3] Testosterone ethosomes for enhanced transdermal delivery [J].

Ainbinder, D ;

Touitou, E .

DRUG DELIVERY, 2005, 12 (05) :297-303

[4]

[Anonymous], ENCY PHARM TECHNOLOG

[5] Novel mechanisms and devices to enable successful transdermal drug delivery [J].

Barry, BW .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114

[6] Percutaneous absorption of a new antiandrogen included in liposomes or in solution [J].

Bernard, E ;

Dubois, JL ;

Wepierre, J .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :235-243

[7] Iontophoresis of lecithin vesicles of cyclosporin A [J].

Boinpally, RR ;

Zhou, SL ;

Devraj, G ;

Anne, PK ;

Poondru, S ;

Jasti, BR .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 274 (1-2) :185-190

[8] Lecithin vesicles for topical delivery of diclofenac [J].

Boinpally, RR ;

Zhou, SL ;

Poondru, S ;

Devraj, G ;

Jasti, BR .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (03) :389-392

[9] Skin structure and mode of action of vesicles [J].

Bouwstra, JA ;

Honeywell-Nguyen, PL .

ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 :S41-S55

[10] Transidermal drug delivery of insulin with ultradeformable carriers [J].

Cevc, G .

CLINICAL PHARMACOKINETICS, 2003, 42 (05) :461-474

← 1 2 3 4 5 6 7 8 9 10 →